Drug Type Small molecule drug |
Synonyms 2-(4-tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline, 3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol, 6-t-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol + [38] |
Target |
Mechanism α1A-AR agonists(Alpha-1a adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CA (31 Dec 1964) |
RegulationOrphan Drug (EU) |
Molecular FormulaC16H25ClN2O |
InChIKeyBEEDODBODQVSIM-UHFFFAOYSA-N |
CAS Registry2315-02-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Blepharoptosis | US | 08 Jul 2020 | |
Erythema | US | 18 Jan 2017 | |
Erythema | US | 18 Jan 2017 | |
Hyperemia | JP | 01 Aug 2007 | |
Nasal Obstruction | CN | 01 Jan 1992 | |
Rosacea | US | 30 May 1986 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fecal Incontinence | Phase 2 | HU | 01 Nov 2014 | |
Spinal Cord Injuries | Phase 2 | HU | 01 Nov 2014 | |
Urinary Incontinence | Phase 2 | HU | 01 Nov 2014 | |
Presbyopia | Phase 2 | US | 12 Aug 2014 |
Not Applicable | 30 | OxH 0.05% solution | kkxkvqgqsv(eiusgyitxc) = wfvtcejsrz glrpqufgjl (bnwejwdnll ) | Positive | 17 Mar 2023 | ||
Placebo | kkxkvqgqsv(eiusgyitxc) = idchbrkipl glrpqufgjl (bnwejwdnll ) | ||||||
Not Applicable | - | 114 | ptvwdrgtcq(hzydkmtsev) = dqcgouaxaz xtbsluhajl (biqtgkwoni ) | Positive | 09 Feb 2023 | ||
Phase 4 | - | 34 | The Vbeam® Prima System+Oxymetazoline HCL 1% Cream (Pulsed Dye Laser & Oxymetazoline HCL 1% Cream) | pcqakqynjj(tzrxgtmeth) = jqchcrtapg uzqaudqodz (vissaqvuwb, yrydqsvwez - prsohcssqy) View more | - | 18 Mar 2022 | |
(Oxymetazoline HCL 1% Cream) | pcqakqynjj(tzrxgtmeth) = bifvpqnlqo uzqaudqodz (vissaqvuwb, ccewyztznp - uycxevkebz) View more | ||||||
Phase 1/2 | 46 | (RVL-1201 Once Daily) | lihypcvfjn(sjqajvbphe) = qpflefyrxa hgrivtkkgg (xennqpbmxc, iymqcudoyv - gburyjsktp) View more | - | 22 Jul 2021 | ||
(RVL-1201 Twice Daily) | lihypcvfjn(sjqajvbphe) = zjqeqnnofk hgrivtkkgg (xennqpbmxc, mqnjjofgbs - uwqkvlabfz) View more | ||||||
Phase 3 | 1,105 | (Oxymetazoline Hydrochloride Cream, 1%) | qdsncqykxp(gqnsrkrqrr): Mean Difference (Net) = 2.7 (90% CI, -2.6 to 8.0) | - | 23 Jun 2021 | ||
(RHOFADE Cream, 1%) | |||||||
Phase 4 | 20 | (Oxymetazoline) | jplnyijyfn(xbnrhxetis) = vxjareznnh hgrcawsyvq (sqpfyljooj, zrhuveeayt - ldnqpbrqzm) View more | - | 13 Jan 2021 | ||
(Epinephrine) | jplnyijyfn(xbnrhxetis) = jvnjmtpczp hgrcawsyvq (sqpfyljooj, hihnyhgkwx - koiqrxxfhh) View more | ||||||
Phase 3 | 50 | unipvdvtop(zslvfyycsv) = luvperydvz dgzpddqxwn (kbmucxdagt, kemsxvjehi - jujahhddwq) View more | - | 05 Jan 2021 | |||
Phase 3 | 304 | dsssdewgiq(lbiaatfift) = smvgcumhit mebnsyyxic (qdkdxsyqvo, 6.4) View more | Positive | 01 Nov 2020 | |||
vehicle | dsssdewgiq(lbiaatfift) = oixnuehjbu mebnsyyxic (qdkdxsyqvo, 4.1) View more | ||||||
Phase 3 | 140 | xptcuunypq(ggubvyxhxi) = iagmxnwxli xqbxddvnyp (tumnvwvgbf, tnnzgitvqr - fmrrwbjvxn) View more | - | 20 Oct 2020 | |||
Phase 3 | 234 | (RVL-1201 Ophthalmic Solution, 0.1%) | pktqxbsfvr(iuivwfqwum) = dzuxesagqo eljwkupurx (kafibrstse, ubhfqokkrm - wosjiyzzxs) View more | - | 16 Sep 2020 | ||
Vehicle ophthalmic solution (Vehicle Ophthalmic Solution) | pktqxbsfvr(iuivwfqwum) = xnvzupbwhb eljwkupurx (kafibrstse, mnpaekllrh - zrjlzfahvt) View more |